Literature DB >> 20445249

Crystallization and preliminary X-ray crystallographic analysis of human phosphodiesterase 12.

Tetsuya Kohno1, Hiroto Yamaguchi, Toshio Hakoshima.   

Abstract

Phosphodiesterase PDE12 is a medically important esterase-family member that hydrolyzes 2'-5'-linked oligoadenylates (2-5A), which are involved in the regulation of biological processes related to the antiviral and antitumour activity that can be induced by interferons. Here, cloning, purification and crystallization of the C-terminal endonuclease/exonuclease/phosphatase-homology domain of human PDE12 is reported. The crystals belonged to space group P3(1)21 or P3(2)21, with unit-cell parameters a = b = 111.3, c = 192.4 A, and diffracted to 2.5 A resolution. Assuming the presence of three molecules in the asymmetric unit, the solvent content was estimated to be about 44.0%.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445249      PMCID: PMC2864682          DOI: 10.1107/S1744309110008766

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  14 in total

Review 1.  The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties.

Authors:  D Rebouillat; A G Hovanessian
Journal:  J Interferon Cytokine Res       Date:  1999-04       Impact factor: 2.607

2.  Identification of 2'-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon.

Authors:  Kazuishi Kubota; Kaori Nakahara; Toshiaki Ohtsuka; Shuku Yoshida; Junko Kawaguchi; Yoko Fujita; Yohei Ozeki; Ayako Hara; Chigusa Yoshimura; Hidehiko Furukawa; Hideyuki Haruyama; Kimihisa Ichikawa; Makoto Yamashita; Tatsuji Matsuoka; Yasuteru Iijima
Journal:  J Biol Chem       Date:  2004-06-30       Impact factor: 5.157

3.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

4.  Structural elucidation of A-74528, an inhibitor for 2',5'-phosphodiesterase isolated from Streptomyces sp.

Authors:  Yoko Fujita; Atsushi Kasuya; Yoichi Matsushita; Miwa Suga; Masaaki Kizuka; Yasuteru Iijima; Takeshi Ogita
Journal:  Bioorg Med Chem Lett       Date:  2005-10-01       Impact factor: 2.823

5.  Purification and characterization of a 2'-phosphodiesterase from bovine spleen.

Authors:  M I Johnston; W G Hearl
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

6.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

7.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

8.  Degradation by the 2',5'-phosphodiesterase activity of mouse cells requires the presence of a ribo hydroxyl group in the penultimate position of the oligonucleotide substrate.

Authors:  P F Torrence; D Alster; S Huss; G Gosselin; J L Imbach
Journal:  FEBS Lett       Date:  1987-02-23       Impact factor: 4.124

9.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

10.  2',5'-Phosphodiesterase activity depends upon the presence of a 3'-hydroxyl moiety in the penultimate position of the oligonucleotide substrate.

Authors:  D Alster; D Brozda; Y Kitade; A Wong; R Charubala; W Pfleiderer; P F Torrence
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

View more
  1 in total

Review 1.  Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke.

Authors:  Haitao Wang; Uma Gaur; Jiao Xiao; Bingtian Xu; Jiangping Xu; Wenhua Zheng
Journal:  Int J Biol Sci       Date:  2018-10-03       Impact factor: 6.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.